These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24197438)

  • 1. Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010.
    Vranić-Ladavac M; Bedenić B; Minandri F; Ištok M; Bošnjak Z; Frančula-Zaninović S; Ladavac R; Visca P
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):471-8. PubMed ID: 24197438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
    Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
    Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic characterization of carbapenem-resistant
    Abouelfetouh A; Torky AS; Aboulmagd E
    Antimicrob Resist Infect Control; 2019; 8():185. PubMed ID: 31832185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
    Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B
    Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35.
    Castanheira M; Costello SE; Woosley LN; Deshpande LM; Davies TA; Jones RN
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7358-66. PubMed ID: 25267671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
    Kouyama Y; Harada S; Ishii Y; Saga T; Yoshizumi A; Tateda K; Yamaguchi K
    J Infect Chemother; 2012 Aug; 18(4):522-8. PubMed ID: 22327516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of different carbapenemase genes among carbapenem-resistant
    Wang TH; Leu YS; Wang NY; Liu CP; Yan TR
    Antimicrob Resist Infect Control; 2018; 7():123. PubMed ID: 30338061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility profile of
    Sharma S; Banerjee T; Yadav G; Kumar A
    Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
    Manageiro V; Jones-Dias D; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2012 Nov; 40(5):398-403. PubMed ID: 22890192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
    Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
    J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran.
    Sohrabi N; Farajnia S; Akhi MT; Nahaei MR; Naghili B; Peymani A; Amiri Z; Rezaee MA; Saeedi N
    Microb Drug Resist; 2012 Aug; 18(4):385-9. PubMed ID: 22352411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of OXA type beta-lactamases and PFGE patterns in Acinetobacter baumannii strains resistant to carbapenems].
    Keyik S; Arslan U; Türk Dağı H; Seyhan T; Fındık D
    Mikrobiyol Bul; 2014 Oct; 48(4):556-65. PubMed ID: 25492651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.
    Aly MM; Abu Alsoud NM; Elrobh MS; Al Johani SM; Balkhy HH
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1759-1766. PubMed ID: 27527351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain.
    Villalón P; Valdezate S; Medina-Pascual MJ; Carrasco G; Vindel A; Saez-Nieto JA
    J Antimicrob Chemother; 2013 Mar; 68(3):550-3. PubMed ID: 23143900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.
    Ahmed SS; Alp E; Ulu-Kilic A; Dinc G; Aktas Z; Ada B; Bagirova F; Baran I; Ersoy Y; Esen S; Guven TG; Hopman J; Hosoglu S; Koksal F; Parlak E; Yalcin AN; Yilmaz G; Voss A; Melchers W
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1463-8. PubMed ID: 27259712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.
    Ruiz M; Marti S; Fernandez-Cuenca F; Pascual A; Vila J
    Clin Microbiol Infect; 2007 Dec; 13(12):1192-8. PubMed ID: 17850347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
    Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
    J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.